Neospark Pharma Private Limited

Neospark Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24230TG1994PTC018667 Incorporated 01 November 1994 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹53.18 Lakh
▲ 101% YoY
Net profit · FY 2025
₹22.78 Lakh
Net margin 42.8%
EBITDA · FY 2025
₹33.34 Lakh
EBITDA margin 62.7%
Authorised capital
₹60 Lakh
Registered with MCA
Paid-up capital
₹50.05 Lakh
Issued & subscribed
Open charges
₹95.5 Cr
Satisfied ₹27.5 Lakh
Company age
32 yrs
Est. 1994
Employees · EPFO
1
Provident fund records

About Neospark Pharma Private Limited

Data last updated:

Neospark Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 01 November 1994 and has been in existence for over 32 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG1994PTC018667. Its GSTIN is 36AAACN7971L1ZX (Telangana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹50.05 Lakh. It is led by directors including Chandra Sekhar Gannamaneni (Managing Director) and Madhavee Latha Vemulapalli.

Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 241 B.L.Baghpunjagutta Hyderabad, Telangana, India – 500082.

As per the financials filed for FY 2025, the company reported a revenue of ₹53.18 Lakh, a growth of 101% compared to the previous year. For the same year it recorded a net profit of ₹22.78 Lakh (net margin 42.8%) and EBITDA of ₹33.34 Lakh (EBITDA margin 62.7%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 17% over five years.

The company has about 1 employee on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹95.5 Cr and satisfied charges of ₹27.5 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website neospark.co.in.

Company details

CIN U24230TG1994PTC018667
Registration Number 018667
Incorporation Date 01 November 1994
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 22 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

CIN history

Neospark Pharma has one previous CIN (Corporate Identification Number): U24230AP1994PTC018667. The current CIN is U24230TG1994PTC018667, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230TG1994PTC018667Current
U24230AP1994PTC018667Previous

Contact details

Neospark Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is neospark.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    241 B.L.Baghpunjagutta Hyderabad, Telangana, India – 500082
  • Industry
    Pharma, Animal Pharmaceuticals & Healthcare

To see the full contact details of Neospark Pharma Private Limited, buy the company report.

Comprehensive company report
Neospark Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Neospark Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Financials of Neospark Pharma Private Limited

FY 2025 filings available

Neospark Pharma Private Limited reported revenue of ₹53.18 Lakh (up 101% YoY) for FY 2025.

Revenue · FY 2025
₹53.18 Lakh ▲ 101%
Net profit · FY 2025
₹22.78 Lakh margin 42.8%
EBITDA · FY 2025
₹33.34 Lakh margin 62.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 101%
3 years · compounded
▲ 27%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 310%
3 years · compounded
▲ 151%
5 years · compounded
▲ 197%

Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 101% growth in the latest year. EBITDA rose 310% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹33.34 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹22.78 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin62.7%
Net Profit Margin42.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Neospark Pharma Private Limited, buy the company report.

Board of directors of Neospark Pharma Private Limited

Neospark Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Madhavee Latha VemulapalliDirector06 Jul 20215 Years 3 MonthsCurrent
Ankamma Rao UyyuruDirector01 Nov 199431 Years 11 MonthsCurrent
Kumara Swamy MuppalaDirector01 Nov 199431 Years 11 MonthsCurrent
Siva Prasad VemulapalliDirector01 Nov 199431 Years 11 MonthsCurrent
Chandra Sekhar GannamaneniManaging Director01 Nov 199431 Years 11 MonthsCurrent

Auditor

Neospark Pharma Private Limited is audited by R.N. Krishna & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
R.N. Krishna & AssociatesFY 2023001475S

Shareholding

The shareholding of Neospark Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Neospark Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹95.5 Cr
Satisfied charges
₹27.5 Lakh
Breakdown by lending institutions
State Bank of India₹95.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
23 May 201110296002State Bank of India₹95.5 CrOpen
20 Mar 200290134539State Bank of India₹3 LakhSatisfied
10 Dec 199890134174State Bank of India₹24.5 LakhSatisfied

To see the full charge records of Neospark Pharma Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Neospark Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Neospark Pharma Private Limited has a workforce of 1 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.

Employee count
1
Active EPFO establishments
1

GST

Neospark Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
36AAACN7971L1ZXTelanganaActive01 Jul 2017

To see the full GST registrations and return filing status of Neospark Pharma Private Limited, buy the company report.

Recent activity

Neospark Pharma Private Limited has 9 board changes on record since 1994: 5 appointments and 4 cessations. The latest: Madhavee Latha Vemulapalli ceased to be Additional Director on 30 Sep 2021.

AGM
Neospark Pharma Private Limited last Annual general meeting of members was held on 22 Sep 2025 as per latest MCA records.
Filing
Neospark Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with State Bank Of India of Rs. 9,550.00 Lakh registered on 23 May 2011 with Charge ID 10296002 was modified on 20 Nov 2023.
Charges
A charge registered on 20 Mar 2002 via Charge ID 90134539 with State Bank Of India was fully satisfied on 14 Oct 2021.
Charges
A charge registered on 10 Dec 1998 via Charge ID 90134174 with State Bank Of India was fully satisfied on 14 Oct 2021.
Ceased
Madhavee Latha Vemulapalli ceased to be Additional Director.
Appointed
Madhavee Latha Vemulapalli was appointed as Director.
Ceased
Vemulapalli Shobha ceased to be Director.
Ceased
Chandra Sekhar Gannamaneni ceased to be Director.
Ceased
Siva Prasad Vemulapalli ceased to be Managing Director.
Charges
A charge with State Bank Of India of Rs. 24.50 Lakh registered on 10 Dec 1998 with Charge ID 90134174 was modified on 13 Aug 2011.
Charges
A charge with State Bank Of India amounted to Rs. 9,550.00 Lakh with Charge ID 10296002 was registered on 23 May 2011.

7 earlier events are in the company report.

Frequently asked questions

Neospark Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 01 November 1994 (32+ years old) and is registered under CIN U24230TG1994PTC018667.

Neospark Pharma has 5 current directors:

The latest financial statements of Neospark Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Neospark Pharma is 36AAACN7971L1ZX, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Neospark Pharma is U24230TG1994PTC018667. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Neospark Pharma was incorporated on 01 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Hyderabad.

Madhavee Latha Vemulapalli ceased to be Additional Director on 30 Sep 2021. Madhavee Latha Vemulapalli was appointed as Director on 06 Jul 2021. Vemulapalli Shobha ceased to be Director on 06 Jan 2021. Neospark Pharma has 9 board changes on record in total.

Neospark Pharma can be reached through the website neospark.co.in. Its registered office is in Hyderabad, Telangana, India.

The registered office of Neospark Pharma is at 241 B.L.Baghpunjagutta Hyderabad, Telangana, India – 500082.

Neospark Pharma operates in the pharma industry, in the animal pharmaceuticals and healthcare segment.